These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12141831)

  • 1. Diabetes mellitus during interferon therapy for chronic viral hepatitis.
    Mofredj A; Howaizi M; Grasset D; Licht H; Loison S; Devergie B; Demontis R; Cadranel JF
    Dig Dis Sci; 2002 Jul; 47(7):1649-54. PubMed ID: 12141831
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection.
    Tasi TN; Hsieh CH
    N Z Med J; 2004 Dec; 117(1207):U1230. PubMed ID: 15608817
    [No Abstract]   [Full Text] [Related]  

  • 5. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
    Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
    Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
    Chatterjee S
    J Assoc Physicians India; 2004 Jun; 52():514. PubMed ID: 15645973
    [No Abstract]   [Full Text] [Related]  

  • 7. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of severe diabetic keto-acidosis with shock after changing interferon-beta into interferon-alpha for chronic hepatitis C.
    Hayakawa M; Gando S; Morimoto Y; Kemmotsu O
    Intensive Care Med; 2000 Jul; 26(7):1008. PubMed ID: 10990121
    [No Abstract]   [Full Text] [Related]  

  • 9. Triggering of acute alcoholic hepatitis by alpha-interferon therapy?
    Ferenci P; Steindl-Munda P
    J Hepatol; 2000 May; 32(5):873. PubMed ID: 10845679
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy.
    Jabr FI; Ordinario MM
    Am J Med; 2003 Aug; 115(2):158-9. PubMed ID: 12893407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-α-related microscopic polyangiitis in a patient with chronic hepatitis C infection.
    Oh SY; Jones BE; Fernando SL
    Med J Aust; 2011 Oct; 195(7):385-6. PubMed ID: 21978341
    [No Abstract]   [Full Text] [Related]  

  • 13. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease.
    Narváez I; Pérez B; del Mar Alcalde M; Jiménez C; Soria A
    Am J Gastroenterol; 2003 Oct; 98(10):2336-7. PubMed ID: 14572601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic hepatitis C in a 12-year-old girl coinfected with HGV].
    Szaflarska-Szczepanik A; Loś E; Krenska-Wiacek A; Chrobot A
    Pol Merkur Lekarski; 1999 Jul; 7(37):21-2. PubMed ID: 10522407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
    Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R
    Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden onset of diabetic ketoacidosis during consensus interferon therapy for chronic viral hepatitis C.
    Nylen ES; Marathe IC; Khan IA; Azevedo R; Hirsch KR
    Am J Med Sci; 2008 Apr; 335(4):329-30. PubMed ID: 18414077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Convulsive seizure during a treatment with interferon alpha for chronic viral hepatitis C].
    Verger P; De Monredon J; Blais J
    Gastroenterol Clin Biol; 1997; 21(11):902-3. PubMed ID: 9587549
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon treatment in chronic HCV hepatitis and autoimmune hypothyroidism].
    Calvo Manuel E; Nieto Sánchez A; Espinos Pérez D
    An Med Interna; 2000 Mar; 17(3):164-5. PubMed ID: 10804649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.